WallStreetZenWallStreetZen
Analyst Ranking
Bottom 19%
#3174 out of 3861 analysts
Average Return
-75.2%
Win Rate
0%0 out of 2
Risk vs Reward
Poor
Good

Daniel Busby's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
No Ratings Available
Daniel Busby doesn't have any winning ratings in our database

Daniel Busby's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Verrica Pharmaceuticals IncVRCA
2Hold$4.00+5.82%Downgrades
3 months ago
Endo International PLCENDP
1Hold$5.00N/AMaintains
a year ago
Agile Therapeutics IncAGRX
1Buy$5.00N/AMaintains
a year ago
Pfizer IncPFE
1Hold$44.00N/AMaintains
a year ago
Mannkind CorpMNKD
1Hold$5.00N/AInitiates Coverage On
a year ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.